
NEW YORK, Nov. 28, 2017 — Rowley Law PLLC is investigating potential claims against MGC Diagnostics Corporation (NASDAQ: MGCD) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by Altus Capital Partners, Inc. MGC stockholders will receive $11.03 in cash for each share of MGC they hold. The transaction is valued at approximately $50.3 million and is expected to close in late 2017 or early 2018.
Powered by WPeMatico